Transgene Biotek P/E Ratio
Transgene Biotek (TRABI) P/E ratio is not applicable — EPS (TTM) ₹-0.22, 7 consecutive loss quarters. See Healthcare Services peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has been reporting losses for 7 consecutive quarters. P/E ratio cannot be calculated for loss-making companies.
Consecutive Loss Quarters: 7
Current EPS: ₹-0.22
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | -0.06 | -1 | Loss |
| Sept 2025 | -0.05 | 0 | Loss |
| Mar 2025 | -0.09 | -1 | Loss |
| Jun 2025 | -0.06 | 0 | Loss |
| Dec 2025 | -0.05 | 0 | Loss |
| Sept 2024 | -0.01 | 0 | Loss |
| Mar 2024 | -0.04 | 0 | Loss |
| Jun 2024 | 0.03 | 0 | Profit |
Healthcare Services Peers with Valid P/E Ratios — TRABI Comparison
Healthcare Services sector average P/E 108.18, median 42.24 — TRABI excluded (negative EPS).
Sector Average PE
108.18
Sector Median PE
42.24
Lowest PE
8.86
Profitable Companies
58
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 8.86 | ₹169 | Low |
| Abate AS Industries | ABATEAS | 12.29 | ₹153 | Low |
| Deccan Health Care | DECCAN | 12.87 | ₹32 | Low |
| Nidan Labs & Healthcare | NIDAN | 12.92 | ₹19 | Low |
| Shanmuga Hospital | SHANMUGA | 14.55 | ₹63 | Low |
| 3B BlackBio DX | 3BBLACKBIO | 16.52 | ₹1,043 | Moderate |
| Invicta Diagnostic | INVICTA | 17.4 | ₹85 | Moderate |
| One Global Service Provi… | ONEGLOBAL | 17.64 | ₹1,178 | Moderate |
| Sangani Hospitals | SANGANI | 17.65 | ₹62 | Moderate |
| Krsnaa Diagnostics | KRSNAA | 18.04 | ₹1,769 | Moderate |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Transgene Biotek share price screener.
- Read TRABI dividend track record for the complete payout history and dividend yield track record.
- See TRABI P/B ratio history to compare market price against book value per share.